StonvexLoading…
StonvexStonvexStonvexCore line items from GCMG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $557.57M | $514.01M | $445.00M | $446.53M |
Operating Income | $133.45M | $73.48M | $-11.85M | $80.31M |
Net Income | $45.37M | $18.70M | $12.77M | $19.82M |
EPS (Diluted) | $0.42 | $0.03 | $-0.28 | $0.28 |
Total Assets | $813.76M | $612.73M | $504.94M | $488.93M |
Total Liabilities | $686.33M | $703.07M | $616.17M | $582.94M |
Cash & Equivalents | $242.12M | $89.45M | $44.35M | $85.16M |
Free Cash Flow OCF − CapEx | $175.04M | $132.04M | $88.30M | $215.73M |
Shares Outstanding | 197.29M | 190.59M | 187.43M | 188.57M |